New Relic, Inc. (NEWR)

Longboard Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 7, 2023	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Market Capitalization	-	5,186	4,426	3,877	2,740	5,661
Market Cap Growth	57.43%	17.18%	14.14%	41.52%	-51.60%	37.75%
Enterprise Value	-	4,956	4,228	3,605	2,496	5,342
PS Ratio	-	5.60	5.63	5.81	4.57	11.81
PB Ratio	-	14.27	12.85	9.29	6.98	16.07
P/TBV Ratio	-	41.55	38.35	16.60	8.61	19.95
P/FCF Ratio	-	102.38	-	75.83	77.83	78.39
P/OCF Ratio	-	96.45	1221.23	55.50	29.33	49.00
EV/Sales Ratio	-	5.35	5.38	5.40	4.16	11.15
EV/EBITDA Ratio	-	-	-	-	-	349.45
EV/FCF Ratio	-	97.84	-	70.52	70.90	73.98
Debt / Equity Ratio	0.10	1.51	1.62	1.24	1.26	1.15
Debt / EBITDA Ratio	-	-	-	-	344.84	26.55
Debt / FCF Ratio	0.46	10.85	-	10.12	14.01	5.62
Asset Turnover	0.88	0.65	0.56	0.50	0.51	0.63
Quick Ratio	1.49	1.13	2.05	2.14	2.53	2.74
Current Ratio	1.58	1.16	2.15	2.27	2.66	2.90
Return on Equity (ROE)	-33.83%	-50.52%	-60.94%	-47.15%	-24.44%	-14.72%
Return on Assets (ROA)	-3.39%	-6.42%	-9.13%	-8.02%	-4.55%	-2.70%
Return on Capital (ROIC)	-5.49%	-10.06%	-14.04%	-11.71%	-6.50%	-4.25%
Earnings Yield	-	-3.48%	-5.66%	-4.97%	-3.25%	-0.72%
FCF Yield	-	0.98%	-0.05%	1.32%	1.29%	1.28%
Buyback Yield / Dilution	-4.72%	-4.68%	-5.77%	-4.21%	-3.02%	-3.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q